ABSTRACT Purpose: The current study aimed to investigate proof-of-concept efficacy of an individualized, robotmediated training regime for people with MS (pwMS) and stroke patients.
INTRODUCTION
People with a neurological disease such as stroke [1, 2] or Multiple Sclerosis (MS) [3, 4] may experience upper limb dysfunction. Unilateral motor deficit leads to chronic upper extremity impairment in 40% of stroke patients [5] [6] [7] while half the people with MS (pwMS) report to have unilateral or bilateral upper limb dysfunction, even in early stage of the disease [3, [8] [9] [10] . Muscle weakness, spasticity, loss of coordination and sensory disorders of the upper limbs may occur in both pwMS and stroke patients [3, 11] . An adequate upper limb function is crucial to independently perform activities of daily living (ADL) such as eating, self-care, typing, carrying and manipulating objects [12] .
Consequently, upper limb dysfunction may have a major impact on patients' quality of life and their level of independence [9, 13] .
Reviews and practical guidelines [14] [15] [16] for upper limb rehabilitation in stroke have concluded that therapy should be applied as intense as possible and be available as out-patient training modality given the reduction of upper limb capacity after discharge from specialized centres [1, 14] . Further improvement of upper function in stroke patients can be obtained by additional motor training and variability in training content [17] [18] [19] . Recently, more attention is directed towards robot-assisted training since it allows higher intensity, task-oriented and autonomous training. Evidence showed that robot-assisted therapy can improve arm-hand performance in chronic stroke patients and is increasingly considered to be as effective compared to conventional comparison treatment [20, 21] .
Rehabilitation research focusing on the upper limb function in MS is limited compared to research performed in other neurological diseases such as stroke [16] . Recent reviews concluded that different type of upper limb rehabilitation strategies can improve upper limb function in pwMS [22, 23] .
However, it is still not clear whether (robot-mediated) upper limb training is successful in pwMS to the same extent as stroke patients, due to progressive neurodegeneration and presence of motor fatigue potentially interfering with feasible training intensity [24, 25] . As in stroke, new training technologies, focusing on robotic and/or sensor-based technology, are being developed to improve upper limb movement in pwMS and indications for improvement were found in previous studies [26] [27] [28] . However, previous studies mainly included pwMS with relatively mild disability and treatment options with regard to independent training for patients with marked to severe arm dysfunction are lacking. To increase therapy compliance, games can be implemented in training approaches. A recent review of Taylor et al. (2014) in MS showed that serious games in a virtual learning environment have the advantage that patients can experience success during training, increasing motivation for intensive and long-term active motor training, and allow for independent training as well [29] . In our previous pilot RCT investigating the feasibility and effectiveness of 6 weeks of additional, robot-mediated, I-TRAVLE training for the upper limb in MS, no significant change on body functions and structures and activity level of the ICF could be demonstrated despite improved motor coordination [30] . However, assessment might not have been comprehensive enough, while a training intensity of 30 minutes daily might have been too long and exercise progression not sufficient enough. During the pilot RCT, an initial version of the I-TRAVLE system allowed patients to train upper limb function by means of basic motor function exercises and serious games but adapting training difficulty was not applied in a systematic way.
To improve the constant provision of an optimal training load, we developed a software architecture that made adaptations to the continuously changing and possibly improving capabilities of the subjects using it, including training intensity and difficulties of the tasks [31] . Therefore, system adaptivity was integrated in the upgraded version of the I-TRAVLE system that was used for the present intervention study. An individualized, autonomous and intensive training regime was applied, featuring the updated I-TRAVLE system. The general aim of the current trial was to obtain proof of concept evidence on the efficacy of additional and individualized, adaptive robot-mediated I-TRAVLE training to improve upper limb function and skill performance in pwMS and chronic stroke patients with low to moderate proximal muscle strength or limited active range of motion of the arm. Written informed consent was obtained from all included patients. The trial has been registered in the Clinical Trials GOV register (code: NCT01918748).
Experimental design and procedure
In this prospective cohort study, pwMS attended 5 training sessions per 2 weeks, alternating 3 and 2 training sessions every other week, during 8 consecutive weeks whereas chronic stroke patients attended 3 training sessions per week during 6 consecutive weeks. Belgian subjects were either hospitalized at the rehabilitation centre or visiting the centre ≥three times per week on an ambulant basis for study purpose. Dutch subjects visited the hospital 3 times per week to attend the robot- [26] [27] [28] 30] . In pwMS with overall high disability, a more extensive but more time-spread training program was required taking into account the occurrence of activity-related motor fatigue and higher risk for training overload [24] .
In chronic stroke patients and unilateral affected pwMS, the impaired arm was trained. In pwMS with bilateral arm dysfunction, the most affected arm according to the MI, was chosen. If both arms were equally affected, the preferred arm was trained. Training focused on motor control, strength, endurance and coordination of the arm. The same therapists (L.K., M.L. and S.S.) executed both the testing and the training. To optimize interrater reliability between testers in different centres, a familiarization session with regard to the selected outcome measures was organized before the start of the study while a detailed instruction manual was available.
Robot-mediated intervention
The Haptic Master (HM) served as a hardware interface (MOOG, the Netherlands) for the I-TRAVLE training ( Figure 1 ). By means of a n ADL gimbal (MOOG, the Netherlands) to fixate the hand and offer support throughout movements of the upper limb during games based on ADL, the HM can be controlled and the patient can move in the virtual learning environment by means of an avatar that is shown on the screen. I-TRAVLE is the acronym for Individualized, Technology-supported and RobotAssisted Virtual Learning Environments (Interreg IV "I-TRAVLE" IVA VLANED 1.58; see www.i- [33] . A selection of basic motor function exercises as well as serious games, all inspired by the ADL items of the Motor Activity Log, have been implemented in the I-TRAVLE system [34] . Basic motor function exercises are skill components of arm movement that can be trained separately, such as reaching, lifting, transporting, rubbing, pushing and pulling ( Figure 2 ). In the serious games, several skill components are combined. For instance, figure 3 presents the 'chicken and eggs'-game, which purpose is to collect as many eggs as possible and push or pull the foxes away. This specific game requires lifting, transporting, pushing and pulling of the arm. assistive/ resistive forces toward the target. Furthermore, the current I-TRAVLE system applies a semi-automatic approach of adaptivity which means that the system suggests the level of difficulty, based on changes in movement performance parameters detected by the system during the previous 2 training sessions, but the suggestions can be confirmed or refused by a human user [24, 31] .
At the beginning of each training session, the individual workspace of the subject in the virtual learning environment is defined. Subsequently, all basic motor function exercises and serious games shoulder anteflexion, whereas the hand is held at a height of approximately 50% between shoulder and knee position [35] .
Descriptive and clinical outcome measures
At baseline, the Neurological Fatigue Index for pwMS (NFI-MS) and stroke patients (NFI-stroke) was administered to document fatigue, the Modified Ashworth Scale (MAS) was used to assess patient's level of spasticity and the Symbol Digit Modalities Test (SDMT) to assess cognitive function. Clinical outcome measures at different ICF levels were selected. On body functions and structures level, the Motricity Index (MI) [36] , active maximum and 10" sustained shoulder range of motion (ROM) by means of the mini digital protractor inclinometer and Jamar handgrip strength [37] were performed.
The Wolf Motor Function Test (WFMT) [38] was used as a capacity measure on activity level and perceived everyday performance of the impaired arm was measured by the ABILHAND [39] .
Perceived fatigue and strength were assessed by means of a Visual Analogue Scale (VAS) at baseline, after training and at follow-up.
Robot-generated outcome measures
After the first and last week of training, subjects performed an evaluation module, implemented in the I-TRAVLE system. Active range of arm movement was determined in six directions i.e. forward, backward, upward, downward, lateral and medial. For the skill components transporting (lateral and medial directions), reaching (forward and backward directions) and lifting (upward and downward directions), movement velocity and hand path ratio were measured. The system automatically stores movement duration, shortest distance between two targets and real distance covered, allowing to determine the above mentioned parameters. Movement velocity (m/s) is the actual covered distance divided by movement duration. Movement quality in terms of hand path ratio (HPR) is the actual covered distance divided by the straight-line distance between the starting point and target.
Performance of three skill components was repeated 3 times and subsequently mean values were used for statistical analysis. PwMS experienced significantly more and severe physical and general fatigue (p<.001) at baseline compared to chronic stroke patients, based on the NFI and VAS of perceived fatigue. Furthermore, median score on the SDMT was lower in stroke patients compared to pwMS (Table 1 ).
*** insert Figure 4 about here *** *** insert Table 1 about here ***
Group comparison
At baseline, both groups differed significantly on active maximum and sustained shoulder anteflexion ROM, the total score of the MI, and the functional ability and time needed to perform activities of the WMFT (p <0.05). Both patient groups presented moderate to severe upper limb dysfunction at baseline but chronic stroke patients had worse upper limb function compared to pwMS (Table 2 ).
Perceived performance of upper limb function did not differ between groups.
Clinical outcome measures
In pwMS, significant improvement was found in active maximum and sustained shoulder anteflexion ROM, handgrip strength and perceived strength at body functions and structures level ( In chronic stroke patients, an increase in handgrip strength, MI scores and perceived strength was found after training and maintained at follow-up (Table 2) . Time needed to perform the activities of the WMFT test decreased over time, indicating faster movement performance. However, these changes
were not statistically significant, except for perceived arm strength.
Robot-generated outcome measures
PwMS showed a significant improvement in movement velocity during transporting, while movement velocity improved significantly for all movement directions in chronic stroke patients (Table 3) .
Furthermore, stroke patients were able to move the affected arm forward, upward and sideward significantly faster after training.
*** insert weeks of upper limb training with the Armeo Spring exoskeleton [28] . In three more studies using a two-dimensional end-effector robot, the NHPT [42] or Action Research Arm test (ARAT) [43, 44] which assess fine motor function and dexterity was used, revealing a positive impact of robot training [26, 27, 45] . This is one of the few studies in MS on robot-mediated training that included a measure on perceived upper limb performance of daily life activities. Unfortunately, no improvements over time Improvements are mirrored by emerging evidence in pwMS of brain plasticity and preservation [46, 47] .
Unfortunately, 12 weeks of follow-up after I-TRAVLE training showed that benefits were not retained. This is in support of Gijbels et al (2011) who included a follow-up period of 2 months and reported a decrease on activity measures as well [28] . Both studies indicate that weekly continued training is essential. An independent exercise programme in a home environment or tele-rehabilitation would be useful to continue training and maintain functionality [48] .
Chronic stroke patients
No significant improvement on clinical outcome measures was found in chronic stroke patients although raw data suggested they improved on maximal anteflexion, MI and handgrip strength, felt subjectively stronger in the arm and needed less time to perform the activities of the WMFT. In contrast with the lack of improvement on the clinical measures, significant improvement on robot-generated parameters was found in chronic stroke patients. Velocity and duration of arm movements during transporting, reaching and lifting improved in stroke patients. Most robotic and sensor-based systems for arm and hand function practice movements in single joints and along single movement planes, reducing motor impairment but failing to improve performance of ADL [55, 56] .
Training effects seem context and task-specific, and transfer to other functional activities cannot be assumed [50] . The I-TRAVLE system and HM allow patients to train 3-dimensional movements, aiming to improve ADL.
Methodological considerations
Compared to most other robot-mediated training programmes, I-TRAVLE is particularly developed based on the principles of motor learning and the system is adaptive to a subject's individual capacity and training progression. The I-TRAVLE system allows patient-tailored rehabilitation and training of proximal skill components of upper limb function which are needed for ADL. Using the HM robot, haptic feedback can be provided to either support or challenge the participants. Furthermore, a more intensive and adaptive training protocol was applied since training sessions consisted of twice 30 minutes of training instead of 1 hour continuously, taking into account the risk of motor fatigue and training overload. An individualized and autonomous approach was applied to constantly challenge participants to perform better and make progress. However, based on the results in chronic stroke patients, training intensity or duration might not been long enough.
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• Robot-mediated therapy allows for adapted training difficulty. An itemized response to all points raised is given below. All the suggestions and remarks are numbered and the corresponding answer is stated beneath starting with A/.
We hope to have given a satisfactory answer to the different comments. If there are any further questions, we are prepared to provide further information or make adaptations if requested.
Sincerely,
The authors
Reviewer 1
Minor revisions 1. Abstract: In methods there are named clinical outcome measures and robot-generated outcome measures (velocity, range of motion and distance), whereas in results first it is stated that no significant change in clinical outcome was found in SP, except for perceived strength. But then it is stated that significant improvement in speed and movement duration was found for all. A bit confusing. We suggest to separate before-after and follow-up, since e.g. in results you describe "upper limb function at baseline" and in next sentence, "...significant improvements were found in a...." -if it is improvement, was it after training or at follow-up? From second and third sentence in abstract -results cannot be clearly understood when they happened. What about follow-up? In the paper it is presented more clearly. 3. In Methods and in Discussion it is written that stroke patients had 6 weeks of training, however on Figure 4 it is written 8 weeks of I-TRAVLE training for both groups.
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